Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism

Brain Research

Volumn 953, Issue 1-2, 2002, Pages 53-62

  Rashid, Md Harunor ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Aminobutyric acid; Analgesia; Intrathecal; Neuropathic pain; Nicotinic acetylcholine receptor; Nicotinic agonist

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; BICUCULLINE; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; MECAMYLAMINE; METHYLLYCACONITINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; PICROTOXIN; RECEPTOR SUBTYPE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GABAERGIC SYSTEM; HYPERALGESIA; MALE; MOUSE; NERVE INJURY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SPINAL CORD;

ANALGESICS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; INJECTIONS, SPINAL; MICE; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; SCIATIC NERVE; SCIATICA; SPINAL CORD;

EID: 0037145712     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03270-5     Document Type: Article

References (35)

1. Badio B., Daly J.W. Epibatidine, a potent analgesic and nicotinic agonist. Mol. Pharmacol. 45:1994;563-569.
2. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D.L., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
3. Bitner R.S., Nikkel A.L., Curzon P., Donnelly-Roberts D.L., Puttfarcken P.S., Namovic M., Jacobs I.C., Meyer M.D., Decker M.W. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat. Brain Res. 871:2000;66-74.
4. Buisson B., Vallejo Y.F., Green W.N., Bertrand D. The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptor. Neuropharmacology. 39:2000;2561-2569.
5. Cordero-Erausquin M., Changeux J.P. Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl. Acad. Sci. USA. 98:2001;2803-2807.
6. Curzon P., Nikkel A.L., Bannon A.W., Arneric S.P., Decker M.W. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (±)epibatidine in rats. J. Pharmacol. Exp. Ther. 287:1998;847-853.
7. Damaj M.I., Fei-Yin M., Dukat M., Glassco W., Glennon R.A., Martin B.R. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J. Pharmacol. Exp. Ther. 284:1998;1058-1065.
8. Dobolyi A., Ueda H., Uchida H., Palkovits M., Usdin T.B. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc. Natl. Acad. Sci. USA. 99:2002;1651-1656.
9. Gillberg P.G., Hartvig P., Gordh T., Sottile A., Jansson I., Archer T., Post C. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat. Psychopharmacology. 100:1990;464-469.
10. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
11. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
12. Idanpaan-Heikkila J.J., Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain. 79:1999;281-290.
13. Iwamoto E.T. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. J. Pharmacol. Exp. Ther. 251:1989;412-421.
14. Jurna I., Krauss P., Baldauf J. Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord. Clin. Invest. 72:1993;65-73.
15. Kesingland A.C., Gentry C.T., Panesar M.S., Bowes M.A., Vernier J.M., Cube R., Walker K., Urban L. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain. 86:2000;113-118.
16. Khan I.M., Taylor P., Yaksh T.L. Stimulatory pathways and sites of action of intrathecally administered nicotinic agent. J. Pharmacol. Exp. Ther. 271:1994;1550-1557.
17. Khan I.M., Buerkle H., Taylor P., Yaksh T.L. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology. 37:1998;1515-1525.
18. Lloyd G.K., Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J. Pharmacol. Exp. Ther. 292:2000;461-467.
19. Luetje C.W., Wada K., Rogers S., Abramson S.N., Tsuji K., Heinemann S., Patrick J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55:1990;632-640.
20. Malmberg A.B., Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain. 76:1998;215-222.
21. McDonough J.H. Jr., Shih T.M. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol. Biochem. Behav. 51:1995;249-253.
22. Papke R.L., Sanberg P.R., Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297:2001;646-656.
23. Rao T.S., Correa L.D., Reid R.T., Lloyd G.K. Evaluation of antinociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay. Neuropharmacology. 35:1996;393-405.
24. Roberts R.G., Stevenson J.E., Westerman R.A., Pennefather J. Nicotinic acetylcholine receptors on capsaicin-sensitive nerves. Neuroreport. 6:1995;1578-1582.
25. Rogers D.T., Iwamoto E.T. Multiple spinal mediators in parenteral nicotine-induced antinociception. J. Pharmacol. Exp. Ther. 267:1993;341-349.
26. Rueter L.E., Meyer M.D., Decker M.W. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain. Brain Res. 872:2000;93-101.
27. Sahley T.L., Berntson G.G. Antinociceptive effects of central and systemic administrations of nicotine in the rat. Psychopharmacology. 65:1979;279-283.
28. Smith M.D., Yang X.H., Nha J.Y., Buccafusco J.J. Antinociceptive effect of spinal cholinergic stimulation: interaction with substance P. Life Sci. 45:1989;1255-1261.
29. Stiller C.O., Cui J.G., O'Connor W.T., Brodin E., Meyerson B.A., Linderoth B. Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery. 39:1996;367-374.
30. Tsuda M., Suzuki T., Misawa M., Nagase H. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur. J. Pharmacol. 307:1996;7-14.
31. Ward J.M., Cockcroft V.B., Lunt G.G., Smillie F.S., Wonnacott S. Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 270:1990;45-48.
32. Woolf C.J., Shortland P., Coggeshall R.E. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 355:1992;75-78.
33. Yaksh T.L., Dirksen R., Harty G.J. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 117:1985;81-88.
34. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.
35. Zoli M., Lena C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18:1998;4461-4472.